Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Glutrox Ultra is an oral nutraceutical supplement developed and marketed by Wonne International. It is formulated as a sachet containing a combination of glutathione and ceramosides, designed for antioxidant support and skin-care supplementation. Glutathione is a tripeptide that serves as a major endogenous antioxidant, neutralizing reactive oxygen species and supporting detoxification processes, which can help reduce oxidative damage to skin cells. Ceramosides are a patented complex of phytoceramides and digalactosyl diglycerides that help to replenish the skin's lipid barrier, thereby improving moisture retention, elasticity, and overall skin texture. The product is commercially available in India as part of Wonne International's product portfolio.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Glutrox Ultra.